Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus

Clinical trial NCT01709929 · COMPLETED

Trial details

NCT number: NCT01709929
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Start date: 2005-10-01
Primary completion: 2006-04-01
Enrollment: 2287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.